# A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

> **NCT07103148** · PHASE3 · RECRUITING · sponsor: **Sanofi** · enrollment: 2440 (estimated)

## Conditions studied

- Yellow Fever Immunization

## Interventions

- **BIOLOGICAL:** Yellow fever vaccine (live)
- **BIOLOGICAL:** Yellow fever vaccine (live)
- **BIOLOGICAL:** Yellow fever vaccine (live)
- **BIOLOGICAL:** Measles, combinations with mumps and rubella, live attenuated

## Key facts

- **NCT ID:** NCT07103148
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-11
- **Primary completion:** 2026-08-08
- **Final completion:** 2030-03-04
- **Target enrollment:** 2440 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07103148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07103148, "A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07103148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*